Orgalutran Special Precautions

Special care should be taken in women with signs and symptoms of active allergic conditions. Cases of hypersensitivity reactions (both generalized and local), have been reported with Orgalutran, as early as with the first dose, during post-marketing surveillance. These events have included anaphylaxis (including anaphylactic shock), angioedema, and urticaria (see Adverse Reactions). If a hypersensitivity reaction is suspected, Orgalutran should be discontinued and appropriate treatment administered. In the absence of clinical experience, Orgalutran treatment is not advised in women with severe allergic conditions.
The needle shield of this medicinal product contains dry natural rubber/latex which comes into contact with this product and may cause allergic reactions (see Contraindications).
The safety and efficacy of Orgalutran have not been established in women weighing less than 50 kg or more than 90 kg.
Effects on ability to drive and use machines: The effects of Orgalutran on ability to drive and use machines have not been studied.